Skip to main navigation
Axsome Corporate Homepage
  • About Axsome
      About Axsome
    • All
    • Overview
    • Management Team
    • Board of Directors
    • Intellectual Property
    • State Disclosures
  • Portfolio
      Portfolio
    • All
    • Products Overview  down arrow
        Products Overview
      • All
      • Overview
      • Sunosi® (solriamfetol)
    • Pipeline Overview  down arrow
        Pipeline Overview
      • All
      • Overview
      • AXS-05
      • AXS-07
      • AXS-12
      • AXS-14
  • Conditions
      Conditions
    • All
    • Overview
    • Depression
    • Migraine
    • Alzheimer’s
      Disease Agitation
    • Excessive Daytime
      Sleepiness
    • Narcolepsy
    • Fibromyalgia
    • Smoking Cessation
  • Axsome Corporate Homepage
  • Science
      Science
    • All
    • Overview
    • Medical Information U.S.
    • Medical Information International
    • Publications
  • Investors
      Investors
    • All
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Information
    • News & Events
    • Webcasts &
      Presentations
    • Analyst Coverage
    • Shareholder Services
  • Careers
      Careers
    • All
    • Overview
    • Current Opportunities

Events

Events

Events

News Releases Events

Upcoming Events

More events are coming soon.

Past Events

Date Event Supporting Materials
March 15, 2023 at 11:20 AM EDT
2nd Annual Needham Virtual Neuroscience Forum
Click here for Webcast
February 27, 2023 at 8:00 AM EST
Axsome Fourth Quarter and Full Year 2022 Financial Results
Click here for Webcast
August 19, 2022 at 8:00 AM EDT
Axsome Therapeutics Auvelity FDA Approval Call
Click here for Webcast
June 28, 2022 at 9:00 AM EDT
Sunosi® Investor Update Virtual Event
Click here for Webcast
  • About Axsome
    • All
    • Overview
    • Management Team
    • Board of Directors
    • Intellectual Property
    • State Disclosures
  • Portfolio
    • All
    • Products Overview
    • Products Overview
    • Auvelity™ (dextromethorphan-bupropion)
    • Sunosi® (solriamfetol)
    • Pipeline Overview
    • AXS‑05
    • AXS‑07
    • AXS‑12
    • AXS‑14
  • Conditions
    • All
    • Overview
    • Depression
    • Migraine
    • Alzheimer's
      Disease Agitation
    • Excessive Daytime
      Sleepiness
    • Narcolepsy
    • Fibromyalgia
    • Smoking Cessation
  • Science
    • All
    • Overview
    • Medical Information U.S.
    • Medical Information International
    • Publications
  • Investors
    • All
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Information
    • News & Events
    • Webcasts &
      Presentations
    • Analyst Coverage
    • Shareholder Services
  • Careers
    • All
    • Careers
    • Current Opportunities
Axsome
  • Contact Us
  • Privacy Notice
  • Terms of Use
  • See Axsome Therapeutics on Twitter
  • See Axsome Therapeutics on LinkedIn

© 2023 Axsome Therapeutics, Inc. All rights reserved. 22 Cortlandt St, 16th Floor, New York, NY 10007 info@axsome.com